Micronized progesterone: vaginal and oral uses.
Simon
J A
JA
Department of Obstetrics and Gynecology, Georgetown University School of Medicine, Washington, DC 20007, USA.
D000282:Administration, Intravaginal; D000284:Administration, Oral; D000568:Amenorrhea / Q000188:drug therapy / Q000453:epidemiology; D002986:Clinical Trials as Topic; D004717:Endometrium / Q000187:drug effects; D005260:Female; D006801:Humans; D007752:Obstetric Labor, Premature / Q000188:drug therapy / Q000453:epidemiology; D016471:Ovarian Hyperstimulation Syndrome / Q000188:drug therapy; D011208:Powders; D011247:Pregnancy; D011293:Premenstrual Syndrome / Q000188:drug therapy / Q000453:epidemiology; D011374:Progesterone / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D011208:Powders; D011374:Progesterone